Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Innovative therapies for treatment of invasive fungal diseases].
Mellinghoff SC, Cornely OA, Mammadova P, Sprute R, Stemler J. Mellinghoff SC, et al. Dtsch Med Wochenschr. 2024 May;149(10):560-568. doi: 10.1055/a-2132-9240. Epub 2024 Apr 24. Dtsch Med Wochenschr. 2024. PMID: 38657595 Review. German.
[Use of an mRNA-based RSV PreF vaccine in older adults].
Mellinghoff SC, Cornely OA, Nitschmann S. Mellinghoff SC, et al. Inn Med (Heidelb). 2024 May;65(5):527-529. doi: 10.1007/s00108-024-01696-1. Epub 2024 Apr 9. Inn Med (Heidelb). 2024. PMID: 38592455 German. No abstract available.
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres.
Rutz J, Naendrup JH, Bruns C, Classen AY, Salmanton-García J, Seifert H, Sprute R, Stemler J, Walker SV, Cornely OA, Liss BJ, Mellinghoff SC; SALT study group. Rutz J, et al. Among authors: mellinghoff sc. JAC Antimicrob Resist. 2024 Apr 4;6(2):dlae046. doi: 10.1093/jacamr/dlae046. eCollection 2024 Apr. JAC Antimicrob Resist. 2024. PMID: 38577701 Free PMC article.
Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.
Salmanton-García J, Bruns C, Rutz J, Albertsmeier M, Ankert J, Bernard L, Bataille C, Couvé-Deacon E, Fernández-Ferrer M, Fortún J, Galar A, Grill E, Guimard T, Classen AY, Vehreschild JJ, Stemler J, Naendrup JH, Hampl J, Tallon B, Sprute R, Horcajada JP, Mollar-Maseres J, Muñoz P, Pletz MW, Serracino-Inglott F, Soriano A, Vilz TO, Seifert H, Cornely OA, Mellinghoff SC, Liss BJ, Wingen-Heimann SM; SALT study group. Salmanton-García J, et al. Among authors: mellinghoff sc. J Hosp Infect. 2024 Mar 11;147:123-132. doi: 10.1016/j.jhin.2024.02.019. Online ahead of print. J Hosp Infect. 2024. PMID: 38467251 Free article.
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Mellinghoff SC, Robrecht S, Sprute R, Mayer L, Weskamm LM, Dahlke C, Gruell H, Teipel F, Schlößer HA, Siepmann K, Thelen M, Fink AM, Fischer K, Klein F, Addo MM, Kolovou A, Cornely OA, Eichhorst B, Hallek M, Langerbeins P. Mellinghoff SC, et al. Eur J Haematol. 2024 May;112(5):788-793. doi: 10.1111/ejh.14170. Epub 2024 Feb 4. Eur J Haematol. 2024. PMID: 38311570
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
Mayer L, Weskamm LM, Fathi A, Kono M, Heidepriem J, Krähling V, Mellinghoff SC, Ly ML, Friedrich M, Hardtke S, Borregaard S, Hesterkamp T, Loeffler FF, Volz A, Sutter G, Becker S, Dahlke C, Addo MM. Mayer L, et al. Among authors: mellinghoff sc. NPJ Vaccines. 2024 Jan 26;9(1):20. doi: 10.1038/s41541-023-00801-z. NPJ Vaccines. 2024. PMID: 38278816 Free PMC article.
Staphylococcus aureus surgical site infection rates in 5 European countries.
Mellinghoff SC, Bruns C, Albertsmeier M, Ankert J, Bernard L, Budin S, Bataille C, Classen AY, Cornely FB, Couvé-Deacon E, Fernandez Ferrer M, Fortún J, Galar A, Grill E, Guimard T, Hampl JA, Wingen-Heimann S, Horcajada JP, Köhler F, Koll C, Mollar J, Muñoz P, Pletz MW, Rutz J, Salmanton-García J, Seifert H, Serracino-Inglott F, Soriano A, Stemler J, Vehreschild JJ, Vilz TO, Naendrup JH, Cornely OA, Liss BJ. Mellinghoff SC, et al. Antimicrob Resist Infect Control. 2023 Sep 19;12(1):104. doi: 10.1186/s13756-023-01309-w. Antimicrob Resist Infect Control. 2023. PMID: 37726843 Free PMC article.
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Stemler J, Mellinghoff SC, Khodamoradi Y, Sprute R, Classen AY, Zapke SE, Hoenigl M, Krause R, Schmidt-Hieber M, Heinz WJ, Klein M, Koehler P, Liss B, Koldehoff M, Buhl C, Penack O, Maschmeyer G, Schalk E, Lass-Flörl C, Karthaus M, Ruhnke M, Cornely OA, Teschner D. Stemler J, et al. Among authors: mellinghoff sc. J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143. J Antimicrob Chemother. 2023. PMID: 37311136 Free PMC article. Review.
60 results